Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on INT 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1235856C reveals a novel carbonylation route for phenylacetic acid derivatives, offering significant cost reduction and purity improvements for API manufacturing.
Patent CN101503365A details a mild NaBH4/I2 reduction for Venlafaxine intermediates, offering high purity and cost-effective scalable manufacturing for global supply chains.
Novel oxidation and crystallization process enhances purity and yield for pharmaceutical intermediates, offering significant supply chain and cost advantages for global manufacturers.
Patent CN102531985A reveals a one-step Grignard route for Ezetimibe intermediates, eliminating palladium catalysts and significantly reducing manufacturing costs.
Patent CN103387566B reveals a low-cost synthesis route for Dabigatran intermediates. Achieve high purity and supply chain stability with optimized crystallization processes.
Patent CN101848911A reveals a chromatography-free method for carbapenem intermediates. Achieve high purity and solid-state stability for reliable supply chain integration.
Patent CN117625571A reveals high-tolerance ketoreductase for ezetimibe intermediate. Enhances purity and reduces manufacturing costs for pharmaceutical supply chains.
Advanced synthesis of neutral endopeptidase inhibitor intermediates. Reliable supply chain for cardiovascular pharmaceutical intermediates with optimized cost and scalability.
Patent CN106432388B details a 4-step synthesis for Sofosbuvir intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel synthesis route for PARP inhibitor intermediates offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Novel three-step synthesis for Ramelteon intermediate ensures high yield and eco-friendly production. Reliable pharmaceutical intermediate supplier for global scale-up and cost reduction.
Novel three-step synthesis for ramelteon intermediate ensures high purity and scalable production for global pharmaceutical supply chains efficiently.
Patent CN102010400A details a novel chiral resolution route for Rotigotine intermediates, offering high purity and streamlined manufacturing for reliable pharmaceutical supply chains.
Patent CN117701523A reveals solvent-tolerant transaminase for high-purity sitagliptin intermediate manufacturing with significant supply chain cost reduction.
Patent CN111004190A reveals a robust Suzuki coupling route for aprepitant intermediates, offering safer scale-up and cost reduction in API manufacturing.
Patent CN112028806B reveals a novel synthetic method for Vildagliptin intermediates, achieving 99.7% purity and 80.6% yield through stabilized cyanuric chloride dehydration.
Novel method for (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate. High yield, mild conditions, scalable process for antiviral drugs.
Novel condensation method for Argatroban intermediate ensures high purity and scalable production. Reduces impurities significantly for reliable pharmaceutical supply chains.
Novel Boc-protection route eliminates palladium hydrogenation. Reduces cost and complexity for ticagrelor intermediate manufacturing. Reliable supply chain partner.
Discover the novel hydrazide-based synthesis of Pramlintide (CN111499719B). High-purity API intermediate manufacturing with optimized fragment coupling and scalable oxidation processes.